~ Agreement grants VectorY the exclusive right to evaluate and license Shape’s non-invasive, deep-brain penetrating AAV5-derived capsid for vectorized antibodies against three targets ~ ~ License will ...
Shape Therapeutics, Inc. (ShapeTX), a next-generation gene therapy company with an industry-leading RNA targeting technology platform, announces today the unveiling of the AAVid TM capsid discovery ...
WEST LAFAYETTE, Ind. – New findings in research led by Purdue University biologists provide further evidence that the protein envelope protecting DNA in viruses evolved billions of years ago from a ...
CHAMPAIGN, Ill. — Researchers report that they have determined the precise chemical structure of the HIV capsid, a protein shell that protects the virus's genetic material and is a key to its ...
Because viruses have to hijack someone else’s cell to replicate, they’ve gotten very good at it—inventing all sorts of tricks. A new study from two University of Chicago scientists has revealed how ...
Key PointsResearch on HIV's conical capsid that began over 25 years ago led to the development of lenacapavir, the world's first capsid inhibitor.In ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback